427 420

Cited 17 times in

Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin

Authors
Yoon, MJ; Park, SS; Kang, YJ; Kim, IY; Lee, JA; Lee, JS; Kim, EG; Lee, CW; Choi, KS
Citation
Carcinogenesis, 33(3):492-500, 2012
Journal Title
Carcinogenesis
ISSN
0143-33341460-2180
Abstract
Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) induces apoptosis selectively in cancer cells while sparing normal cells. However, many cancer cells are resistant to TRAIL-induced cell death. In this study, we examined whether Aurora B, which is frequently overexpressed in cancer cells, is associated with TRAIL resistance. The protein levels of Aurora B were higher in TRAIL-resistant cancer cell lines than in TRAIL-sensitive cancer cell lines. Exogenously expressed Aurora B attenuated TRAIL-induced apoptosis in the tested TRAIL-sensitive cancer cell lines, whereas the small interfering RNA-mediated suppression of Aurora B expression stimulated TRAIL-mediated apoptosis in the tested TRAIL-resistant cancer cell lines. Furthermore, combined treatment with TRAIL and ZM447439, a specific inhibitor of Aurora B, synergistically induced apoptosis in various TRAIL-resistant cancer cells, suggesting that this combined regimen may represent an attractive strategy for effectively treating TRAIL-resistant malignant cancers. Mechanistically, the inhibition of Aurora B activity in various cancer cells commonly downregulated survivin protein levels and potentiated the activation of caspase-3. In addition, Aurora B inhibition induced mitotic catastrophe, which also contributed to the sensitization of cells to TRAIL-mediated apoptosis. Interestingly, forced overexpression of Aurora B increased the protein levels of survivin, but not those of a non-phosphorylatable survivin mutant in which threonine 117 was replaced by alanine, indicating that phosphorylation of survivin is required for this effect. Furthermore, TRAIL-induced apoptosis in MDA-MB-435S cells was attenuated by wild-type survivin but not by the non-phosphorylatable survivin mutant. Collectively, our results demonstrate that Aurora B confers TRAIL resistance to cancer cells via phosphorylation of survivin.
MeSH terms
*ApoptosisApoptosis Regulatory Proteins/genetics/metabolismBenzamides/pharmacologyCaspase 3/biosynthesis/metabolismCell Line, TumorHep G2 CellsHumansInhibitor of Apoptosis Proteins/*metabolismM Phase Cell Cycle Checkpoints/drug effectsNeoplasmsPhosphorylationProtein-Serine-Threonine Kinases/antagonists & inhibitors/*metabolismQuinazolines/pharmacologyRNA InterferenceRNA, Small InterferingTNF-Related Apoptosis-Inducing Ligand/administration &dosage/metabolism/*pharmacology
DOI
10.1093/carcin/bgr298
PMID
22159225
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Biochemistry & Molecular Biology
AJOU Authors
최, 경숙
Full Text Link
Files in This Item:
492-500.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse